Gastrointestinal hemorrhage
1 paper
- Human trial1
Trial sponsors
Children's National Research Institute
1 trialPhase 4760 people
Maria Sklodowska-Curie National Research Institute of Oncology
1 trialPhase 4760 people
University of British Columbia
1 trialPhase 4122 people
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
Trends in Mortality Due to Heart Failure and Gastrointestinal Hemorrhage in the United States: A Retrospective Analysis of CDC WONDER Database
Study in peoplePopulations
The Lancet Oncology
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Non-randomised trial in 55 peopleSenolytics